Results 71 to 80 of about 191,710 (309)

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Mixed metric dimension over (edge) corona products

AKCE International Journal of Graphs and Combinatorics
A subset S of V(G) is called a mixed resolving set for G if, for every two distinct elements x and y of [Formula: see text], there exists [Formula: see text] such that [Formula: see text].
M. Korivand, K. Khashyarmanesh, M. Tavakoli   +2 more
doaj   +1 more source

On mixed Moore graphs

Discrete Mathematics, 2007
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Nguyen, Minh Hoang, Miller, Mirka, Gimbert, Joan   +2 more
openaire   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Mixed-level detecting arrays on graphs

Electronic Research Archive
The purpose of this paper was to develop a unified combinatorial framework for fault localization in heterogeneous software systems, where parameters may have different numbers of levels.
Quanrui Zhang, Ce Shi, Yonggang Yi
doaj   +1 more source

Mixed unit interval graphs

Discrete Mathematics, 2012
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Dourado, Mitre C., Le, Van Bang, Protti, Fábio, Rautenbach, Dieter, Szwarcfiter, Jayme L.   +4 more
openaire   +2 more sources

Approximation algorithms for orienting mixed graphs [PDF]

Theoretical Computer Science, 2011
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Elberfeld, Michael, Segev, Danny, Davidson, Colin R., Silverbush, Dana, Sharan, Roded   +4 more
openaire   +2 more sources

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Mixed Graph Colouring as Scheduling a Partially Ordered Set of Interruptible Multi-Processor Tasks with Integer Due Dates

Algorithms
We investigate relationships between scheduling problems with the bottleneck objective functions (minimising makespan or maximal lateness) and problems of optimal colourings of the mixed graphs. The investigated scheduling problems have integer durations
Evangelina I. Mihova, Yuri N. Sotskov
doaj   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source